Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Inhibitors (ICIs)”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07599111
What this trial is testing

Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP

Who this might be right for
Pneumonitis, InterstitialImmune Checkpoint Inhibitors (ICIs)Mesenchymal Stem Cells+1 more
Zhou Chengzhi 40
Not applicableLooking for participantsNCT05378334
What this trial is testing

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Guangzhou University of Traditional Chinese Medicine 82
Not applicableLooking for participantsNCT05718492
What this trial is testing

The Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 100
Not applicableStudy completedNCT05942872
What this trial is testing

CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.

Who this might be right for
Paraneoplastic Syndromes
Hospices Civils de Lyon 90
Testing effectiveness (Phase 2)Looking for participantsNCT06163820
What this trial is testing

Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases

Who this might be right for
Melanoma Brain Metastases
Melanoma and Skin Cancer Trials Limited 46
Not applicableActive Not RecruitingNCT02724488
What this trial is testing

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Who this might be right for
Head and Neck CancerMelanoma
University Health Network, Toronto 14
Testing effectiveness (Phase 2)Looking for participantsNCT07157969
What this trial is testing

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital 300
Not applicableStudy completedNCT04975932
What this trial is testing

Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 826
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066216
What this trial is testing

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Fujian Cancer Hospital 45
Not applicableLooking for participantsNCT05862259
What this trial is testing

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

Who this might be right for
Malignant TumorImmunotherapyArtificial Intelligence
Xinqiao Hospital of Chongqing 120
Not applicableUnknownNCT05725915
What this trial is testing

Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell
Beijing Red Clove Public Welfare Development Center 56
Testing effectiveness (Phase 2)Study completedNCT04997382
What this trial is testing

Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT05824481
What this trial is testing

Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Sun Yat-sen University 32
Not applicableStudy completedNCT06435013
What this trial is testing

Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaLenvatinib
Sun Yat-sen University 208
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Large-scale testing (Phase 3)Ended earlyNCT04985136
What this trial is testing

Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 1
Not applicableUnknownNCT05821751
What this trial is testing

The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fondazione del Piemonte per l'Oncologia 40
Not applicableUnknownNCT04492969
What this trial is testing

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

Who this might be right for
NSCLC Stage IVNSCLC, Recurrent
Fudan University 320
Not applicableLooking for participantsNCT05484908
What this trial is testing

Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

Who this might be right for
Immune-Mediated HepatitisLiver FailureHepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University 60
Not applicableStudy completedNCT04352335
What this trial is testing

Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator

Who this might be right for
Advanced Lung Cancer
Chung Shan Medical University 53
Load More Results